bevacizumab,atezolizumab,Irinotecan,Oxaliplatin,L-Leucovorin,5-fluorouracil
Roche
[' bev ', 'atezo']
atezo plus folfoxiri plus bev . trend towards os . will this show benifit in phase 3 also? #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists